The alternativepunishing companies with tariffs or relying on foreign importsis, in the long run, far more costly
Mounjaro tends to win the Mounjaro vs Ozempic decision for patients who: Have obesity (BMI 30) or are overweight with metabolic risk factors, and weight loss is the primary goal Have an HbA1c that hasnt responded well to metformin or older GLP-1 drugs Dont have a strong personal or family history of cardiovascular disease that specifically needs Ozempics proven protective data Can sustain the higher monthly cost for the 12+ months typically needed for lasting results Who Should Consider Ozempic (or Generic Semaglutide)

According to the drug's prescribing information, these potential risks are: An allergic reaction (hypersensitivity) Severe low blood sugar in people with type 2 diabetes, especially those taking insulin or sulfonylureas Complications related to diabetic retinopathy in those with type 2 diabetes Acute pancreatitis or gallbladder disease Acute kidney injury Increases in heart rate Suicidal ideation or behavior Lastly, Wegovy may increase the risk of certain thyroid tumors but this has only been observed in rodent studies
Keeping Track of Your Tests Keep a record of your lab results
NSL literature pointer PMID 6129489 L-Carnitine laboratory index [PMID: 6129489] National Science Labs indexing note for PMID 6129489: review the PubMed methods, models, and limitations before citing
Assessing psychosocial distress in diabetes: development of the diabetes distress scale